FDA · Press release · Rel 92 (FDA Press Announcements)
FDA Approves Once-Weekly Generic Hormone Therapy Patch for Women
Health / life sciences · fda-guidance
Source summary
Today, the U.S. Food and Drug Administration approved the first generic of Climara Pro (estradiol and levonorgestrel transdermal system, 0.045 mg per day/0.015 mg), a transdermal hormone therapy patch for women with an intact uterus applied once a week.
Analyst note
FDA announcement may indicate policy direction in health. Validate against primary text before client guidance.
Public reaction (Reddit)
Insufficient public reaction to score sentiment.